Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
DNE PHARMA AS
AS
Active
Org 991741208
Karihaugveien 22, 1086
Oslo
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2007 · 18 years old
5 employees
Overvåg
Share
Norway
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
DNE PHARMA AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
0M
18M
36M
53M
71M
32M
2020
40M
2021
47M
2022
54M
2023
62M
2024
EBITDA
NOK millions
18M
13M
9M
4M
0M
1M
2020
7M
+600%
2021
9M
+29%
2022
9M
0%
2023
14M
+56%
2024
Income statement
NOK thousands
Item
2020
2021
2022
2023
2024
Revenue
31 713
40 374
46 745
54 192
62 328
Staff expenses
−7 310
−8 203
−7 165
−7 590
−8 519
EBITDA
680
6 796
9 102
9 159
14 240
Depreciation & amort.
−70
−0
−0
−0
−2 933
EBIT
610
6 796
9 102
9 159
11 307
Net financials
−14 644
−511
−540
−749
102
Profit before tax
−14 034
6 285
8 562
8 410
11 409
Tax
337
1 285
1 725
1 803
2 511
Net profit
−14 371
5 000
6 837
6 607
8 898
Balance sheet
NOK thousands
Item
2020
2021
2022
2023
2024
Total assets
76 926
75 668
91 487
83 399
96 529
Equity
41 296
46 026
52 863
59 470
53 368
Long-term debt
6 727
6 619
6 684
7 063
7 313
Short-term debt
26 054
20 220
29 635
16 243
35 718
Total debt
32 781
26 839
36 319
23 305
43 031
Financial ratios
5-year trend
EBITDA-margin
22.8%
This company
15.8%
Market median
+44% vs market
2020
2024
Soliditetsgrad
55.3%
This company
38.2%
Market median
+45% vs market
2020
2024
Egenkapitalforrentning
16.7%
This company
18.4%
Market median
+9% vs market
2020
2024
Nettoresultatgrad
14.3%
This company
8.1%
Market median
+77% vs market
2020
2024
Aktivomsætning
0.65×
This company
1.12×
Market median
-42% vs market
2020
2024
Gæld/egenkapital
0.81×
This company
0.62×
Market median
+31% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
More on DNE PHARMA AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
